Treating advanced hepatocellular carcinoma: How to get out of first gear

Author： Harding James J.   Abou-Alfa Ghassan K.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|20|3122-3130

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.20, 2014-10, pp. : 3122-3130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Complete Response in 5 Out of 38 Patients with Advanced Hepatocellular Carcinoma Treated with Stem Cell Differentiation Stage Factors: Case Reports from a Single Centre

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 2, 2011-02 ,pp. : 254-260

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib: A Review of its Use in Advanced Hepatocellular Carcinoma

By Keating Gillian M.  

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 223-240

Adis International

Access to resources Recommend Favorite

Sorafenib: a guide to its use in advanced hepatocellular carcinoma

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite